Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - Introduction, advantages, risks;Methoden zur vergleichenden ökonomischen evaluation von therapien und zur rationalen ressourcenallokation über bereiche des gesundheitswesens hinweg - Einführung, vorteile, risiken

Psychiatrische Praxis, Supplement

Volumn 28, Issue 1, 2001, Pages

  Wasem, J ^a   Hessel, F ^a   Kerim Sade, C ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; MEDICAL ETHICS; OUTCOMES RESEARCH; QUALITY ADJUSTED LIFE YEAR;

EID: 0034895338     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. The use of cost-effectiveness/cost-benefit analysis in actual decision making: Current status and prospects
2. Are healthy-years equivalents an improvement over quality-adjusted life years?
3. The myth of the HYE
4. The healthy-years equivalents: How to measure them using the standard gamble approach
5. An alternative to QALYs: The saved young life equivalent (SAVE)
6. Valuing health care benefits in money terms
7. A health-status-indes and its applications to health-services outcomes
8. Where now for saving lifes?
9. Utility assessment for estimating quality-adjusted life years
10. Measurement of health state utilities for economic appraisal. A review
11. Gesundheitsökonomische evaluation in der rehabilitation. Teil I: Prinzipien und empfehlungen für die leistungserfassung
12. A scale of valuations of states of illness: Is there a social consensus?
13. Social preferences for health states. An empirical evaluation of three measurement techniques
14. The comparability and reliability of five health state valuation methods
15. Relationship between quality of life instruments, health state utility and willingness to pay in patients with asthma
16. Der effizienz auf der spur: Einführung in die ökonomische evaluation
17. Developing the health care market
18. Economics of coronary artery bypass grafting
19. From cost-effectiveness ratios to resource allocation: Where to draw the line?
20. Foundations of cost-effectiveness analysis for health and medical practices
21. Rationing care in Oregon: The new accountability
22. Cost utility analysis: What should be measured?
23. Utility functions for life years and health status
24. Utilities and quality-adjusted life years
25. The Use of QALYs in health care decision making
26. Cost-Effectiveness League Tables: More harm than good?
27. Decision trees and markov models in cost-effectiveness research
28. Discounting life-years: Whither time preference?
29. Time preference
30. Discounting costs and effects: A reconsideration
31. Discounting health effects for medical decisions
32. Evidence of effectiveness: Evaluating its quality
33. Ordnungspolitische bewertung von kosten-nutzen-analysen aus der sicht der gesetzlichen krankenversicherung
34. Kosten-effektivitätsanalyse und lebensalter
35. QALY League Tables: Handle with care
36. Übertragung ausländischer studienergebnisse aus dem bereich der ökonomischen evaluation auf Deutschland: Probleme und lösungsansätze
37. The relationship between cost-effectiveness analysis and cost-benefit analysis
38. The normative economics of health care finance and provision
39. QALYs: Where next?
40. The qualy and why it should be resisted
41. Prävention, gesundheitsförderung und gesundheitserziehung